Exploring the Temporo-masseteric Nerve Block in Healthy Volunteers
Official title: Non-randomized Pilot Study to Characterize Temporo-masseteric Nerve Block (TMNB) in
Run by Rutgers, The State University of New Jersey · NCT05507164 · Data updated 2026-11-12
This study is testing how a specific nerve block injection affects muscle activity and bite strength in healthy volunteers to see if it can help with pain relief.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Newark, New Jersey) |
| Status | Recruiting |
| Started | October 10, 2022 |
| Main results expected | September 2026 |
| Study ends | December 2026 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT05507164 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18-64 who have no history of temporomandibular disorders or significant orofacial pain.
✕Probably not a fit
Patients with a history of temporomandibular disorders, significant orofacial pain, or those currently undergoing orthodontic treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to characterize the Temporo-masseteric Nerve Block (TMNB) injection in 20 healthy volunteers. It will assess bite-force distribution and surface electromyographic activity of the temporalis and masseter muscles before and after the TMNB injection. Evaluations will occur at 30 minutes, 2 hours, and 2 weeks post-injection, with participants also providing feedback on their experience. The study seeks to understand the TMNB's effects on muscle activity and its potential for sustained pain relief.
Why it matters
Potential benefit: If successful, this study could enhance understanding of TMNB's effectiveness in managing myogenous pain, potentially leading to improved treatment options.
How similar studies have gone: While the TMNB approach is emerging, similar nerve blocks have shown promise in pain management, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-64 years of age * All ethnicity * Male and female sex * Fluent in written/spoken English * Never been diagnosed with TMD * No significant history of orofacial pain * \<5 headaches/month in the 3 months before enrollment * No reported use of a nightguard or occlusal splint 'No' to all questions on self-administered questionnaire for TMD screening: * Pain in jaw or temple on either side of the face in the last 30 days * Stiffness or pain in jaw upon awakening in the last 30 days * Any pain increase/reduction in the jaw/temple region during the last 30 days with * Chewing hard or tough food * Opening mouth or moving jaw forward or to the side * Hold teeth together/clenching/grinding/chewing gum * Using the jaw during activities such as talking, kissing or yawning Exclusion Criteria: * Traumatic injury/ surgery on face or jaw \< 6 months * current orthodontic treatment * pregnant or nursing, * kidney failure or renal dialysis, * heart disease or heart failure, * uncontrolled chronic respiratory disease/ hypertension/ diabetes * history of * seizures * hyperthyroidism * drug or alcohol abuse * psychiatric disorder/conditions requiring hospitalization * chemotherapy/radiation
Where it's running
-
Rutgers School of Dental Medicine
Newark, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Gayathri D Subramanian, DMD — Rutgers School of Dental Medicine
- Study coordinator: Gayathri D Subramanian
- Email: subramga@sdm.rutgers.edu
- Phone: 9739723418
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing cerebral blood flow response using a new index
This study is testing a new way to measure blood flow in the brain to see if it can help identify patients with narrowed or blocked carotid arteries who might need surgery.
-
Confirming the safety and performance of TufTex Embolectomy Catheters
This study is testing a new type of catheter to see if it safely and effectively removes blood clots from arteries in people who are having surgery.
-
Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal
This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.
-
Tenecteplase or Reteplase Bridging Before Thrombectomy in Acute Ischemic Stroke
This trial tests whether giving tenecteplase or reteplase before mechanical thrombectomy helps people with acute ischemic stroke due to large vessel occlusion, compared with doing thrombectomy alone.
-
Intra-arterial Alteplase after successful reperfusion following mechanical thrombectomy
This trial tests whether giving a small amount of alteplase directly into the artery after a successful thrombectomy helps adults with acute ischemic stroke recover better.
-
Sivelestat added to endovascular clot retrieval for acute anterior circulation stroke
This study tests whether giving sivelestat sodium alongside mechanical thrombectomy helps improve outcomes for adults with acute ischemic stroke due to large vessel occlusion.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.